Vestal Point Capital’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-275,000
Closed -$38.5M 82
2025
Q3
$38.5M Buy
+275,000
New +$37.2M 1.74% 20
2024
Q1
Sell
-75,000
Closed -$19.4M 61
2023
Q4
$19.4M Buy
+75,000
New +$18.4M 2.06% 17

Other funds holding BIIB

Vestal Point Capital's BIIB Position: Q4 2025 in Review

Vestal Point Capital sold out of Biogen (BIIB) in Q4 2025, closing a stake of 275,000 shares — an estimated $38.5M sold.

Vestal Point Capital first reported a position in BIIB in Q4 2023 and held it in 2 quarters. The position peaked at $38.5M in Q3 2025. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Vestal Point Capital reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Vestal Point Capital sold 275,000 Biogen shares in Q4 2025, an estimated $38.5M.
  • Vestal Point Capital first reported a position in Biogen in Q4 2023 and held it in 2 quarters.
  • Vestal Point Capital's Biogen position peaked at $38.5M in Q3 2025.
  • 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Vestal Point Capital's 13F filing for Q4 2025, filed 17 Feb 2026.